These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 23292314

  • 1. The oncolytic herpes simplex virus vector G47∆ effectively targets breast cancer stem cells.
    Zeng W, Hu P, Wu J, Wang J, Li J, Lei L, Liu R.
    Oncol Rep; 2013 Mar; 29(3):1108-14. PubMed ID: 23292314
    [Abstract] [Full Text] [Related]

  • 2. An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer.
    Zeng WG, Li JJ, Hu P, Lei L, Wang JN, Liu RB.
    Oncol Rep; 2013 Jun; 29(6):2355-61. PubMed ID: 23525624
    [Abstract] [Full Text] [Related]

  • 3. Oncolytic herpes simplex virus treatment of metastatic breast cancer.
    Wang J, Hu P, Zeng M, Rabkin SD, Liu R.
    Int J Oncol; 2012 Mar; 40(3):757-63. PubMed ID: 22108767
    [Abstract] [Full Text] [Related]

  • 4. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
    Mao J, Song B, Shi Y, Wang B, Fan S, Yu X, Tang J, Li L.
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
    [Abstract] [Full Text] [Related]

  • 5. Treatment of breast cancer stem cells with oncolytic herpes simplex virus.
    Li J, Zeng W, Huang Y, Zhang Q, Hu P, Rabkin SD, Liu R.
    Cancer Gene Ther; 2012 Oct; 19(10):707-14. PubMed ID: 22898897
    [Abstract] [Full Text] [Related]

  • 6. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D, Nawa A, Tanino T, Goshima F, Luo CH, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Tsurumi T, Nishiyama Y, Kikkawa F.
    Cancer Lett; 2010 Feb 01; 288(1):17-27. PubMed ID: 19604626
    [Abstract] [Full Text] [Related]

  • 7. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.
    Yano S, Tazawa H, Hashimoto Y, Shirakawa Y, Kuroda S, Nishizaki M, Kishimoto H, Uno F, Nagasaka T, Urata Y, Kagawa S, Hoffman RM, Fujiwara T.
    Clin Cancer Res; 2013 Dec 01; 19(23):6495-505. PubMed ID: 24081978
    [Abstract] [Full Text] [Related]

  • 8. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
    Zhang Y, Zhang H, Wang X, Wang J, Zhang X, Zhang Q.
    Biomaterials; 2012 Jan 01; 33(2):679-91. PubMed ID: 22019123
    [Abstract] [Full Text] [Related]

  • 9. Oncolytic recombinant herpes simplex virus for treatment of orthotopic liver tumors in nude mice.
    Chung YS, Miyatake S, Miyamoto A, Miyamoto Y, Dohi T, Tanigawa N.
    Int J Oncol; 2006 Apr 01; 28(4):793-8. PubMed ID: 16525626
    [Abstract] [Full Text] [Related]

  • 10. Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures.
    Lim YC, Oh SY, Kim H.
    Exp Cell Res; 2012 Jun 10; 318(10):1104-11. PubMed ID: 22426199
    [Abstract] [Full Text] [Related]

  • 11. Treatment of colon cancer with oncolytic herpes simplex virus in preclinical models.
    Yang H, Peng T, Li J, Wang Y, Zhang W, Zhang P, Peng S, Du T, Li Y, Yan Q, Liu B.
    Gene Ther; 2016 May 10; 23(5):450-9. PubMed ID: 26871935
    [Abstract] [Full Text] [Related]

  • 12. Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability.
    Gu W, Yeo E, McMillan N, Yu C.
    Cancer Gene Ther; 2011 Dec 10; 18(12):897-905. PubMed ID: 21904396
    [Abstract] [Full Text] [Related]

  • 13. Oncolytic reovirus effectively targets breast cancer stem cells.
    Marcato P, Dean CA, Giacomantonio CA, Lee PW.
    Mol Ther; 2009 Jun 10; 17(6):972-9. PubMed ID: 19293772
    [Abstract] [Full Text] [Related]

  • 14. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
    Kang NH, Hwang KA, Yi BR, Lee HJ, Jeung EB, Kim SU, Choi KC.
    Cancer Gene Ther; 2012 Jun 10; 19(6):412-9. PubMed ID: 22498724
    [Abstract] [Full Text] [Related]

  • 15. MiR-125a/b regulates the activation of cancer stem cells in paclitaxel-resistant colon cancer.
    Chen J, Chen Y, Chen Z.
    Cancer Invest; 2013 Jan 10; 31(1):17-23. PubMed ID: 23327190
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966.
    Lee TJ, Nair M, Banasavadi-Siddegowda Y, Liu J, Nallanagulagari T, Jaime-Ramirez AC, Guo JY, Quadri H, Zhang J, Bockhorst KH, Aghi MK, Carbonell WS, Kaur B, Yoo JY.
    Mol Cancer Ther; 2019 Jun 10; 18(6):1127-1136. PubMed ID: 30926634
    [Abstract] [Full Text] [Related]

  • 20. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
    Chang J, Sui M, Fan W.
    Breast Cancer Res Treat; 2012 Aug 10; 134(3):969-80. PubMed ID: 22374518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.